Nasal spray for cluster headache attacks
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial tests a nasal spray medicine called zavegepant to see if it can quickly stop cluster headache attacks. Cluster headaches are very painful headaches that happen in cycles or bouts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with episodic cluster headaches, and your headaches come in bouts (at least 2 bouts in the past).
- Your cluster headaches started before age 50.
- Your headaches usually last at least 45 minutes if you don't treat them.
- You can use a nasal spray device and have access to the internet for study forms.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use birth control.
- You don't have certain heart, liver, kidney, or nasal conditions that could make the study unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with certain severe headache disorders (cluster-type headaches or SUNCT/SUNA) or trigeminal neuralgia (sharp facial nerve pain). Researchers want to better understand these conditions and see how study testing/record review may help care.
This trial tests whether injections of botulinum toxin type A can reduce frequent, severe cluster headache attacks by targeting a facial nerve area. It’s for people whose cluster headaches have not responded well—or have caused side effects—to standard preventive treatments.
This trial tests a procedure that uses targeted pulses of energy and a special blood-platelet solution to calm a specific nerve cluster at the back of the nose, which may reduce the frequency and intensity of cluster headache attacks. It is for people whose headaches have not improved enough with standard preventive medicines.
This Phase 3 trial tests whether repeated injections can reduce attacks of chronic cluster headache. It may help people who have frequent, consistent attacks and can track them closely during the study.
This study tests a nasal spray called zavegepant to see how well it treats migraine attacks quickly. It may help people who have frequent migraines and need a fast-acting treatment.
This trial tests whether the medicine zavegepant (given as a nasal spray) is safe and works well for children aged 6 to 11 who have a history of migraines. If your child gets migraines, this study may help find a new treatment option.
Hear when a new Cluster Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.